Additional Research. Unless it is approved in writing by Sponsor, Institution and Principal Investigator shall not conduct any research not required by the Protocol for the conduct of the Clinical Trial at or by Institution (i) on Trial subjects during the Clinical Trial (including any additional or (ii) on biological samples collected from Trial subjects during the Clinical Trial or the data derived there from. Hereinafter, the research described in the previous sentence shall be referred to as “Additional Research”. In any case where Sponsor gives such approval, the approved Additional Research shall be considered an amendment to the original Protocol, or shall be the subject of another agreement, and Institution and Principal Investigator shall conduct all such research in compliance with all applicable regulations, including requirements for obtaining appropriate EC approval and subject informed consent. Further, if such research is conducted notwithstanding the foregoing restriction, Institution hereby grants to Sponsor an irrevocable, worldwide, paid up, royalty-free, exclusive license, with right of sub-license, to make, have made, use, have used, sell, have sold, and import any invention that results from such Additional Research. This Section shall survive termination or expiration of this Agreement.
Appears in 2 contracts